Predialysis vascular access creation: To whom and when

Detalhes bibliográficos
Autor(a) principal: Escoli,Rachele
Data de Publicação: 2017
Outros Autores: Luz,Ivan, Santos,Paulo, Vila Lobos,Ana
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
Texto Completo: http://scielo.pt/scielo.php?script=sci_arttext&pid=S0872-01692017000300001
Resumo: Aims: The optimal timing of predialysis vascular access surgery remains uncertain. This study goal was to evaluate the influence of kidney function and clinical characteristics at predialysis vascular access surgery on the likelihood of initiating hemodialysis during follow-up. Methods: Our study retrospectively identified all patients undergoing predialysis arteriovenous fistula creation between 2012-2015. We assessed 3 outcomes: frequency of hemodialysis initiation, death before hemodialysis initiation, and dialysis-free survival after vascular access creation. Multiple variable logistic regression analyzed which factors predicted initiation of dialysis. Results: The study involved 202 patients. Using multiple variable logistic regression, 5 factors were associated with hemodialysis initiation: estimated glomerular filtration rate <10 mL/min/1,73m2 at vascular access placement [OR 4.7, CI: 1.98-8,60, p=0.005], diabetes [OR 2.14, CI: 1.07-4,30, p=0.033], proteinuria&gt;1gr/24 hours [OR 1.88, CI: 0.95-3.71, p=0.049], higher phosphorus levels [OR 6.25, CI: 1.39-13.05, p=0.017] and glomerular filtration rate drop ³3mL/min/1.73m2 in the year preceding vascular surgery [OR 1.67, CI: 0.81-3.45, p=0.016]. Cancer and congestive heart failure were associated with dead before starting dialysis [OR 5.9, CI: 1.15-9.78, p=0.038 and OR 2.4, CI: 1.3-3.9, p=0.021, respectively] and higher hemoglobin (&gt;10g/dL) without erythropoietin stimulating agent levels with survival without needing dialysis [OR 2.34, CI: 1.09-4,58, p=0.028]. Conclusions: Optimizing the timing of vascular access creation in predialysis patients requires consideration not only of the kidney function but also comorbidities such as diabetes, estimated glomerular filtration rate decline in the preceding year and degree of proteinuria
id RCAP_955aaec66dbdd20b4ac6ec40252b88c9
oai_identifier_str oai:scielo:S0872-01692017000300001
network_acronym_str RCAP
network_name_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository_id_str 7160
spelling Predialysis vascular access creation: To whom and whenArteriovenous fistulaChronic HemodialysisPre-dialysisVascular AccessAims: The optimal timing of predialysis vascular access surgery remains uncertain. This study goal was to evaluate the influence of kidney function and clinical characteristics at predialysis vascular access surgery on the likelihood of initiating hemodialysis during follow-up. Methods: Our study retrospectively identified all patients undergoing predialysis arteriovenous fistula creation between 2012-2015. We assessed 3 outcomes: frequency of hemodialysis initiation, death before hemodialysis initiation, and dialysis-free survival after vascular access creation. Multiple variable logistic regression analyzed which factors predicted initiation of dialysis. Results: The study involved 202 patients. Using multiple variable logistic regression, 5 factors were associated with hemodialysis initiation: estimated glomerular filtration rate <10 mL/min/1,73m2 at vascular access placement [OR 4.7, CI: 1.98-8,60, p=0.005], diabetes [OR 2.14, CI: 1.07-4,30, p=0.033], proteinuria&gt;1gr/24 hours [OR 1.88, CI: 0.95-3.71, p=0.049], higher phosphorus levels [OR 6.25, CI: 1.39-13.05, p=0.017] and glomerular filtration rate drop ³3mL/min/1.73m2 in the year preceding vascular surgery [OR 1.67, CI: 0.81-3.45, p=0.016]. Cancer and congestive heart failure were associated with dead before starting dialysis [OR 5.9, CI: 1.15-9.78, p=0.038 and OR 2.4, CI: 1.3-3.9, p=0.021, respectively] and higher hemoglobin (&gt;10g/dL) without erythropoietin stimulating agent levels with survival without needing dialysis [OR 2.34, CI: 1.09-4,58, p=0.028]. Conclusions: Optimizing the timing of vascular access creation in predialysis patients requires consideration not only of the kidney function but also comorbidities such as diabetes, estimated glomerular filtration rate decline in the preceding year and degree of proteinuriaSociedade Portuguesa de Nefrologia2017-09-01info:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articletext/htmlhttp://scielo.pt/scielo.php?script=sci_arttext&pid=S0872-01692017000300001Portuguese Journal of Nephrology &amp; Hypertension v.31 n.3 2017reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAPenghttp://scielo.pt/scielo.php?script=sci_arttext&pid=S0872-01692017000300001Escoli,RacheleLuz,IvanSantos,PauloVila Lobos,Anainfo:eu-repo/semantics/openAccess2024-02-06T17:04:55Zoai:scielo:S0872-01692017000300001Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireopendoar:71602024-03-20T02:18:58.601812Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse
dc.title.none.fl_str_mv Predialysis vascular access creation: To whom and when
title Predialysis vascular access creation: To whom and when
spellingShingle Predialysis vascular access creation: To whom and when
Escoli,Rachele
Arteriovenous fistula
Chronic Hemodialysis
Pre-dialysis
Vascular Access
title_short Predialysis vascular access creation: To whom and when
title_full Predialysis vascular access creation: To whom and when
title_fullStr Predialysis vascular access creation: To whom and when
title_full_unstemmed Predialysis vascular access creation: To whom and when
title_sort Predialysis vascular access creation: To whom and when
author Escoli,Rachele
author_facet Escoli,Rachele
Luz,Ivan
Santos,Paulo
Vila Lobos,Ana
author_role author
author2 Luz,Ivan
Santos,Paulo
Vila Lobos,Ana
author2_role author
author
author
dc.contributor.author.fl_str_mv Escoli,Rachele
Luz,Ivan
Santos,Paulo
Vila Lobos,Ana
dc.subject.por.fl_str_mv Arteriovenous fistula
Chronic Hemodialysis
Pre-dialysis
Vascular Access
topic Arteriovenous fistula
Chronic Hemodialysis
Pre-dialysis
Vascular Access
description Aims: The optimal timing of predialysis vascular access surgery remains uncertain. This study goal was to evaluate the influence of kidney function and clinical characteristics at predialysis vascular access surgery on the likelihood of initiating hemodialysis during follow-up. Methods: Our study retrospectively identified all patients undergoing predialysis arteriovenous fistula creation between 2012-2015. We assessed 3 outcomes: frequency of hemodialysis initiation, death before hemodialysis initiation, and dialysis-free survival after vascular access creation. Multiple variable logistic regression analyzed which factors predicted initiation of dialysis. Results: The study involved 202 patients. Using multiple variable logistic regression, 5 factors were associated with hemodialysis initiation: estimated glomerular filtration rate <10 mL/min/1,73m2 at vascular access placement [OR 4.7, CI: 1.98-8,60, p=0.005], diabetes [OR 2.14, CI: 1.07-4,30, p=0.033], proteinuria&gt;1gr/24 hours [OR 1.88, CI: 0.95-3.71, p=0.049], higher phosphorus levels [OR 6.25, CI: 1.39-13.05, p=0.017] and glomerular filtration rate drop ³3mL/min/1.73m2 in the year preceding vascular surgery [OR 1.67, CI: 0.81-3.45, p=0.016]. Cancer and congestive heart failure were associated with dead before starting dialysis [OR 5.9, CI: 1.15-9.78, p=0.038 and OR 2.4, CI: 1.3-3.9, p=0.021, respectively] and higher hemoglobin (&gt;10g/dL) without erythropoietin stimulating agent levels with survival without needing dialysis [OR 2.34, CI: 1.09-4,58, p=0.028]. Conclusions: Optimizing the timing of vascular access creation in predialysis patients requires consideration not only of the kidney function but also comorbidities such as diabetes, estimated glomerular filtration rate decline in the preceding year and degree of proteinuria
publishDate 2017
dc.date.none.fl_str_mv 2017-09-01
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://scielo.pt/scielo.php?script=sci_arttext&pid=S0872-01692017000300001
url http://scielo.pt/scielo.php?script=sci_arttext&pid=S0872-01692017000300001
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv http://scielo.pt/scielo.php?script=sci_arttext&pid=S0872-01692017000300001
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv text/html
dc.publisher.none.fl_str_mv Sociedade Portuguesa de Nefrologia
publisher.none.fl_str_mv Sociedade Portuguesa de Nefrologia
dc.source.none.fl_str_mv Portuguese Journal of Nephrology &amp; Hypertension v.31 n.3 2017
reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron:RCAAP
instname_str Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron_str RCAAP
institution RCAAP
reponame_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
collection Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository.name.fl_str_mv Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
repository.mail.fl_str_mv
_version_ 1799137279675990016